Want to join the conversation?
As of March 31, 2016, $AKAM's cash, cash equivalents and marketable securities, which consisted primarily of corporate bonds and US government agency securities, totaled $1.5Bil. Factoring in convertible senior notes, net cash is $833.2MM. As of March 31, 2016, $AKAM had cash and cash equivalents of $200MM held in accounts outside the US.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.